Scroll up to Strategy

Investments

Bain Capital Life Sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe.

AavantiBio

Affera

Affinivax

Amunix Pharmaceuticals

Amylyx Pharmaceuticals

annexon

arcutis

atea_logo

c4_therapeutics

Cardurion Pharmaceuticals

constellation

freenome

gynesonics

imperative-care

inflarx

Interius BioTherapeutics

jenavalve

kymera

Nautilus Biotechnology

Nuvalent

savara

SpringWorks Therapeutics

Synthekine

BCLS Acquisition Corp.

BCLS Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a business combination with one or more biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies.

Click here to visit the website.

Our team thinks critically about the issues around hard science, clinical trial design, and the regulatory environment in our investment approach.

Scroll down to People